News & Updates

Bina Technologies, a genomic big data platform for personalized medicine, added an additional $1.75 million to its $6.25 million Series B round. The follow-on round was led by AME Cloud Ventures and Columbus Nova Technology Partners.

Researchers developed an algorithm that can identify diabetes patients at the earliest possible date of diagnosis using data extracted from an EHR. Such algorithms could be key for population health management by helping providers identify and reach out to affected patients.

The federal government signed five deals that allow online insurers, like or, to access the federal exchange data hub, which is necessary to allow would-be insurance buyers to have their eligibility for government subsidies verified.

North Carolina passed the Health Care Cost Reduction and Transparency Act that will create an online database of what hospitals are paid, on average, for the most common treatments, surgical and imaging procedures they perform. The law provides more insight as to what hospital bills might be before care is delivered.

Autism researchers at the University of Kansas received a $1.2 million grant from the National Institute on Deafness and Other Communication Disorders, Communication Intervention for Preschoolers Learning to use AAC (CI-PAAC) to test an iPad app to help children with social communication.

Azumio, a health and fitness app developer, announced the integration of its Argus iOS app with Salutron’s physiological monitoring system LifeTrak Move C300. The combined system will help users track comprehensive biofeedback and physiological data to improve their health and well being, as well as allow social network integration with peers.

Ambio, maker of health care monitoring systems, received Class II FDA Clearance 510(k) for its Ambio Remote Health Monitoring System, a wireless remote health and activity monitoring tool. The system will help in tracking health information for patients with high blood pressure, heart disease and diabetes.

A recent study published in the Journal of Clinical Psychiatry found that the FDA approved Proteus ingestible sensor was able to track adherence with 94% accuracy among patients with bipolar disorder or schizophrenia. The clinical trial was conducted in partnership with Massachusetts General Hospital and the Zucker Hillside Hospital.

Terason, maker of portable ultrasound systems, received 510(k) FDA and CE Mark clearance for its tablet based uSmart 3200T Ultrasound System. The tablet is Wi-Fi and Bluetooth enabled, and runs on Windows 7. Earlier this year, FDA approved another portable ultrasound system called the MobiUS TC1.

San Diego county based Sharp Rees-Stealy Medical Centers partnered with Asthmapolis to offer the FDA approved Asthmapolis platform as a part of its asthma respiratory health management program. The platform, consisting of a sensor and supporting app, helps patients and physicians track and manage symptoms and triggers of asthma attacks.

Leave a Reply

Your email address will not be published. Required fields are marked *